Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes

Vatankulu B., Aksoy S. Y., Asa S., SAğER M. S., SAYMAN H. B., Halac M., ...Daha Fazla

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.35, sa.1, ss.17-21, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.remn.2015.07.001
  • Dergi Adı: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.17-21
  • Anahtar Kelimeler: Paraneoplastic neurological syndrome, Positron emission tomography, Malignancy, Paraneoplastic antibodies, POSITRON-EMISSION-TOMOGRAPHY, CT, AUTOANTIBODIES, MALIGNANCY, DISORDERS, TUMORS
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Objective: There is still no consensus about whether to perform PET/CT to detect carcinoma in paraneoplastic neurological syndromes (PNS) in patients with or without antibodies. The aim of this study is to determine the diagnostic accuracy of PET/CT and antibodies in patients with PNS.